Can checking blood pressure at home help kidney transplant patients?
NCT ID NCT04364126
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether kidney transplant recipients with high blood pressure could better control their condition by monitoring their blood pressure at home, compared to standard clinic visits. The trial planned to enroll many participants but was stopped early after only 21 people joined. The goal was to see if home monitoring leads to lower blood pressure and better treatment satisfaction.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Home blood pressure monitoring device
- What this could lead to
- If successful, this approach could help kidney transplant patients manage their blood pressure more effectively at home, potentially reducing heart risks.
- What could go wrong
- The trial was terminated early with only 21 participants, so results are limited and may not apply broadly. Home monitoring may not improve outcomes for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
21 people
The number who actually took part.
- Started
-
Dec 2022
- Finished
-
Jan 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Kidney transplant recipient 2. Male or female subject ≥ 18 years old 3. Any or more of the following at the baseline clinic * Conventional office BP ≥130 mmHg systolic and/or ≥ 80 mmHg diastolic * HBPM ≥125 mmHg systolic and/or ≥ 80 mmHg diastolic measured within the last 3 months (see appendix 1 for details on methodology) * Daytime ambulatory blood pressure monitoring (ABPM) ≥125 mmHg systolic and/or ≥ 80 mmHg diastolic measured within the last 3 months 4. Signed informed consent and expected cooperation of the patient for the treatment and follow up. 5. Have a national personal identification number and not be expected to emigrate during study 6. Enlisted in the Norwegian Renal Registry Exclusion Criteria: 1. Standing systolic BP \< 110 mmHg (to avoid adverse events). Measured after one and three minutes of standing. Not applicable if unable to stand due to wheelchair use. 2. Diagnosed atrial fibrillation (automated monitors not validated) 3. Unwilling to self-monitor 4. Female participant who is pregnant, lactating or planning pregnancy during the trial (management of essential hypertension in pregnancy is different) 5. Arm circumference too large or small to allow accurate BP measurement with available device (22-42 cm). 6. Any reason likely limiting adherence to interventions, as judged by the investigator; examples include active alcohol or substance abuse within the last 12 months, significant poor compliance with medications or attendance at clinic visits, residence in a nursing home, dementia, other medical or psychiatric conditions that may interfere with study participation. 7. Graft- or life expectancy less than 2 years, as judged by the investigator. 8. Current use of ≥ 4 antihypertensive medications 9. More than half of regular appointments planned as remote (e.g. phone or video) consultations. 10. Severe white-coat hypertension, e.g. patients already treated solely based on home BP values. 11. Multi-organ transplants (e.g. heart, lung, liver), though pancreas or beta-cell islet transplant is allowed.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cardiovascular diseases are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Oslo University Hospital, Rikshospitalet
Oslo, Norway
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a nurse and a neighbor help tame chronic disease?
- Can pressing six points on the body help older adults sleep?
- Two eggs a day put to the test for heart health
- A soft patch that watches your heart beat in real time
- Can AI-Tailored heat warnings shield chronic disease patients from dangerous temperatures?
- Could a quieter, automated blood pressure check help more people control hypertension?